Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bocom Industrial Investment (Hangzhou) Equity Investment Partnership is a specialized private equity fund based in Hangzhou, China, managed by BOCOM Capital. As an investment vehicle of the Bank of Communications, the fund targets strategic emerging industries with a primary focus on life sciences, healthcare, and high-end manufacturing. It serves as a bridge between financial capital and industrial innovation, providing funding to growth-stage companies in the biotechnology and medical device sectors. The partnership involves collaborations with local government investment platforms to foster regional economic development and technological advancement. For a biotech analyst, this entity represents a significant source of institutional capital and strategic partnership for companies operating within the Chinese healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bocom Industrial Investment (Hangzhou) Equity Investment Partnership.